Discriminative stimulus properties of cocaine: Enhancement by monoamine reuptake blockers

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 1015-1025

  Kleven, Mark S ^a   Koek, Wouter ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 2 DIBUTYLAMINO 8 HYDROXYTETRALIN; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ALAPROCLATE; AMFEBUTAMONE; BENZATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CITALOPRAM; COCAINE; DESIPRAMINE; DIAZEPAM; DOPAMINE UPTAKE INHIBITOR; FLUOXETINE; HOMOCOCAINE; IMIPRAMINE; INDATRALINE; MAZINDOL; METHYLPHENIDATE; NISOXETINE; NOMIFENSINE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PROCAINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; TALSUPRAM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOPAMINE UPTAKE; DOSE RESPONSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; SEROTONIN UPTAKE;

ANIMALS; COCAINE; DESIPRAMINE; DISCRIMINATION LEARNING; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; NOREPINEPHRINE; PRAZOSIN; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; VENTRAL TEGMENTAL AREA;

EID: 0031911746     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Acri JB, Seidleck BK and Witkin JM (1996) Effects of benztropine on behavioral and toxic effects of cocaine: Comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine. J Pharmacol Exp Ther 277:198-206.
2. Baker LE, Riddle EE, Saunders RB and Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4:69-79.
3. Broadbent J, Michael EK, Riddle EE and Appel JB (1991) Involvement of dopamine uptake in the discriminative stimulus effects of cocaine. Behav Pharmacol 2:187-197.
4. Callahan PM and Cunningham KA (1995a) Analysis of the effects of diverse antidepressants on the discriminative stimulus effects of cocaine, in Problems of Drug Dependence 1994, NIDA Monograph (Harris LS, ed) pp 383, Washington DC, U.S. Government Printing Office.
5. Callahan PM and Cunningham KA (1995b) Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors. J Pharmacol Exp Ther 274:1414-1424.
6. Callahan PM and Cunningham KA (1997) Modulation of the discriminative stimulus properties of cocaine: Comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists. Neuropharmacology 36:373-381.
7. Callahan PM, De La Garza RI and Cunningham KA (1994) Discriminative stimulus properties of cocaine: modulation by dopamine D1 receptors in the nucleus accumbens. Psychopharmacology 115:110-114.
8. Carboni E, Tanda GL, Frau R and Di Chiara G (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: Evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067-1070.
9. Chen N-H and Reith MEA (1994) Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: A microdialysis study on monoamine interrelationships. J Neurochem 63:1701-1713.
10. Chen N-H and Reith MEA (1997) Role of axonal and somatodendritic monoamine transporters in the action of uptake blockers, in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith MEA, ed) pp 345-391, Totowa, NJ, Humana Press Inc.
11. Colpaert FC and Janssen PAJ (1986) Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination. Psychopharmacology 90:222-228.
12. Colpaert FC, Niemegeers CJE and Janssen PAJ (1979) Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol Biochem Behav 10:535-546.
13. Cunningham KA, Bradberry CW, Chang AS and Reith MEA (1995) The role of serotonin in the actions of psychostimulants: Molecular and pharmacological analyses. Behav Brain Res 73:93-102.
14. Cunningham KA and Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104: 177-180.
15. Emmett-Oglesby MW, Wurst M and Lal H (1983) Discriminative stimulus properties of a small dose of cocaine. Neuropharmacology 22:97-102.
16. Fischman MW, Foltin RW, Nestadt G and Perlson GD (1990) Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther 253:760-770.
17. Fuller RW (1993) Biogenic amine transporters. Neurotransmissions 9:1-4.
18. Gauvin DV, Criado JR, Moore KR and Holloway FA (1990) Potentiation of cocaine's discriminative effects by caffeine: A time-effect analysis. Pharmacol Biochem Behav 36:195-197.
19. Gauvin DV, Harland RD, Michaelis RC and Holloway FA (1989) Caffeine-phenylethylamine combinations mimic the cocaine discriminative cue. Life Sci 44:67-73.
20. Giros B, Jaber M, Jones SR, Wightman RM and Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
21. Grenhoff J and Svensson TH (1989) Clonidine modulates dopamine cell firing in the rat ventral tegmental area. Eur J Pharmacol 165:11-18.
22. Harland RD, Gauvin DV, Michaelis RC, Carney JM, Seale TW and Holloway FA (1989) Behavioral interaction between cocaine and caffeine: a drug discrimination analysis in rats. Pharmacol Biochem Behav 32:1017-1023.
23. Harris GC, Hedaya MA, Pan WJ and Kalivas P (1996) β-adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopkarmacology 14:195-204.
24. Heikkila RE and Manzino L (1984) Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake. Eur J Pharmacol 103: 241-248.
25. Herve D, Blanc G, Glowinski J and Tassin JP (1982) Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat. Brain Res 237:510-516.
26. Howell LL and Byrd LD (1995) Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 275:1551-1559.
27. Hubert JJ (1984) Bioassay. Dubuque, IA, Kendall/Hunt.
28. Hyttel J (1982) Citalopram: Pharmacological profile of a specific serotonin uptake inhibitor with antidepress ant activity. Prog Neuro-Psychopharmacol Biol Psychiatry 6:277-295.
29. Hyttel J and Larsen JJ (1985) Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin. J Neurochem 44:1615-1622.
30. Izenwasser S, Werling LL and Cox BM (1990) Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res 520:303-309.
31. Johanson C-E and Barrett JE (1993) The discriminative stimulus effects of cocaine in pigeons. J Pharmacol Exp Ther 267:1-8.
32. 3H]-dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro. J Neurochem 45:137-144.
33. Kleven MS, Assié MB and Koek W (1997) Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. II Drug discrimination and behavioral observation studies in rats. J Pharmacol Exp Ther 282:747-759.
34. Kleven MS and Koek W (1997) Discriminative stimulus properties of cocaine: Enhancement by β-adrenergic receptor antagonists. Psychopharmacology 131:307-312.
35. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649-661.
36. Koek W, Kleven MS and Colpaert FC (1995) Effects of the NMDA antagonist, dizocilpine, in various drug discriminations: Characterization of intermediate levels of drug lever selection. Behau Pharmacol 6:590-600.
37. Lategan AJ, Marien MR and Colpaert FC (1990) Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis. Brain Res 523:134-138.
38. Li MY, Yan QS, Coffey LL and Reith MEA (1996) Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers. J Neurochem 66:559-568.
39. Matecka D, Rothman RB, Radesca L, de Costa BR, Dersch CM, Partilla JS, Pert A, Glowa JR, Wojnicki FHE and Rice KC (1996) Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropy)piperazines (GBR 12935 and GBR 12909). J Med Chem 39:4704-4716.
40. Meert TF and Janssen PAJ (1992) Ritanserin, a new therapeutic approach for drug abuse. Part 2: Effects on cocaine. Drug Deu Res 25:39-53.
41. Nomikos GG, Damsma G, Wenkstern D and Fibiger HC (1991) Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens. Eur J Pharmacol 195:63-73.
42. Peltier RL, Emmett-Oglesby MW, Thomas WH and Schenk S (1994) Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine. Pharmacol Biochem Behav 48:473-478.
43. Reith MEA, Meisler BE, Sershen H and Lajtha A (1986) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 35:1123-1129.
44. Ritz MC, Lamb RJ, Goldberg SR and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223.
45. Rosenzweig-Lipson S, Bergman J, Spealman RD and Madras BK (1992) Stereoselective behavioral effects of Lu 19-005 in monkeys: Relation to binding at cocaine recognition sites. Psychopharmacology 107:186-194.
46. Rothman RB, Lewis B, Dersch C, Xu H, Radesca L, de Costa BR, Rice KC, Kilburn RB, Akunne HC and Pert A (1993) Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters. Synapse 14:34-39.
47. Schama KF, Howell LL and Byrd LD (1997) Serotonergic modulation of the discriminative-stimulus effects of cocaine in squirrel monkeys. Psychopharmacology 132: 27-34.
48. Silvia CP, Jaber M, King GR, Ellinwood EH and Caron MG (1997) Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience 76:737-747.
49. Snedecor GW and Cochran WG (1967) Statistical Methods. Ames, IA, The Iowa State University Press.
50. Snoddy AM and Tessel RE (1985) Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice. Eur J Pharmacol 116:221-228.
51. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112:93-99.
52. Spealman RD (1995) Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 275:53-62.
53. Spealman RD, Bergman J and Rosenzweig-Lipson S (1997) Differential modulation of behavioral effects of cocaine by low-and high-efficacy D1 agonists. Psychopharmacology 133:283-292.
54. Stanford SC (1996) Prozac: Panacea or puzzle? Trends Pharmacol Sci 17:150-154.
55. Tallarida RJ and Murray RB (1987) Manual of Pharmacological Calculations with Computer Programs. New York, Springer Verlag.
56. Tella SR (1995) Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol Biochem Behav 51:687-692.
57. Tella SR and Goldberg SR (1993) Monoamine uptake inhibitors alter cocaine pharmacokinetics. Psychopharmacology 112:497-502.
58. Teneud LM, Baptists T, Murzi E, Hoebel BG and Hernandez L (1996) Systemic and local cocaine increase extracellular serotonin in the nucleus accumbens. Pharmacol Biochem Behav 53:747-752.
59. Terry P, Witkin JM and Katz JL (1994) Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270:1041-1048.
60. Tessel RE and Barrett JE (1986) Antagonism of the behavioral effects of cocaine and d-amphetamine by prazosin. Psychopharmacology 90:436-440.
61. Volkow ND, Gatley SJ, Fowler JS, Logan J, Fischman M, Gifford AN, Pappas N, King P, Vitkun S, Ding YS and Wang GJ (1996) Cocaine doses equivalent to those abused by humans occupy most of the dopamine transporters. Synapse 24:399-402.
62. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R and Shea CE (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827-830.
63. Walsh SL and Cunningham KA (1997) Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology 130:41-58.
64. Walsh SL, Preston KL, Sullivan JT, Fromme R and Bigelow GE (1994) Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol 14:396-407.
65. Witkin JM, Nichols DE, Terry P and Katz JL (1991) Behavioral effects of selective dopamine compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713.
66. Wood DM and Emmett-Oglesby M (1989) Mediation in the nucleus accumbens of the discriminative stimulus produced by cocaine. Pharmacol Biochem Behav 33:453-457.
67. Woodward JJ, Compton DM, Balster RL and Martin BR (1995) In vitro and in vivo effects of cocaine and selected local anesthetics on the dopamine transporter. Eur J Pharmacol 277:7-13.